Form 4: Waters Corp SVP & CFO Amol Chaubal Reports Stock Transactions

Amol Chaubal, SVP & CFO of Waters Corp, reports the acquisition of common stock and stock options, including earned performance shares and restricted stock, according to a Form 4 filing.

Summary

• Amol Chaubal, the SVP & Chief Financial Officer of Waters Corp, filed a Form 4 with the SEC on February 7, 2025.
• The filing reports transactions made on February 5, 2025.
• Chaubal acquired 3,317 shares of common stock related to earned performance shares from a performance stock unit award granted on February 25, 2022.
• These shares will service vest on March 1, 2025.
• He also acquired 833 shares of restricted stock that will vest 20% per annum for a 5-year period beginning February 5, 2026.
• Additionally, Chaubal acquired 4,287 stock options with an exercise price of $414.09, vesting 20% per annum for a five-year period beginning February 5, 2026, and expiring on February 5, 2035.
• Following these transactions, Chaubal directly owns 6,444.495 shares of common stock and 4,287 stock options.
• Chaubal has granted a Power of Attorney to Keeley Aleman, Christina Kelleher, Jodi Brueggeman, and Michael Lynn to handle SEC filings on his behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions, indicating standard compensation practices. There's no explicit positive or negative information about the company's performance.

Positives

• The acquisition of performance shares indicates the achievement of performance goals set by the company's compensation committee.
• The vesting schedule of the restricted stock and stock options incentivizes long-term commitment from the executive.

Future Outlook

The reported transactions reflect ongoing compensation and incentive plans for Waters Corp's executives.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option and restricted stock grants are common compensation practices among publicly traded companies, particularly in the technology and life sciences sectors.
• Vesting schedules, such as the 20% per annum vesting described in the document, are standard for aligning executive incentives with long-term company performance.
• Companies like Agilent Technologies and Thermo Fisher Scientific, which operate in similar industries, also utilize stock-based compensation as part of their executive pay packages.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation.
• The vesting schedules incentivize the executive to contribute to the company's long-term success, potentially benefiting shareholders and employees.

Next Steps

• The earned performance shares will service vest on March 1, 2025.
• The restricted stock and stock options will vest over the next five years, starting February 5, 2026.

Key Dates

Keywords

Form 4, insider trading, stock options, restricted stock, performance shares, Amol Chaubal, Waters Corp, WAT, SEC